Catalyst Financial Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-323
| Closed | -$230K | – | 294 |
|
|
2024
Q4 | $230K | Sell |
323
-6
| -2% | -$4.27K | 0.04% | 247 |
|
|
2024
Q3 | $346K | Buy |
329
+3
| +0.9% | +$3.15K | 0.07% | 183 |
|
|
2024
Q2 | $343K | Buy |
326
+12
| +4% | +$12.6K | 0.08% | 167 |
|
|
2024
Q1 | $283K | Buy |
314
+19
| +6% | +$17.1K | 0.07% | 179 |
|
|
2023
Q4 | $259K | Buy |
295
+9
| +3% | +$7.91K | 0.07% | 184 |
|
|
2023
Q3 | $235K | Buy |
+286
| New | +$235K | 0.08% | 179 |
|